Much of the research at Joslin focuses on gaining an understanding of type 1 and type 2 diabetes at the cellular level. This includes studies of the cellular development of pancreafic beta cells, studies of the development and inflammafion of metabolically active muscle and adipose cells, and studies of the mediators and modifiers of autoimmunity toward beta cells. All of these research areas require analysis and isolation of well-defined, pure, populations of live cells. Flow cytometry and cell sorting within the Flow Core meet this need. Fluorescence activated cell sorting is currently the best method for rapid isolation of very well defined and highly purified, live cells. The Joslin Flow Cytometry Core's primary mission is to provide reliable and affordable cell sorting and flow cytometry services to its users, so that they can isolate, analyze, and study cells that increase our understanding of diabetes and its complications, and ultimately develop treatments and cures for these diseases. Cell sorting technology is confinuously evolving and improving, enabling new approaches to questions in diabetes research. Therefore, a second mission of the Flow Core is to confinually update and modernize to offer the most cutting edge cell sorting technology to its users. In addifion, because flow cytometry is traditionally thought of as an immunology tool, the Joslin Core's mission includes acfivifies that enhance the use of flow cytometry in other research areas, bringing this technology to new users and stimulating new avenues of diabetes research. The specific goals of the Core are: 1. To offer to Joslin researchers the use of reliable, well maintained, cutting edge, and cost-effective cell sorting and analysis machines. 2. To provide education and training to Joslin researchers regarding potential applications of flow cytometry. 3. To confinually update instrumentafion in response to new and cutfing-edge technology developments, including upgrades to exisfing instruments, addifion of new instrumentafion, and establishment of collaborative arrangements to help develop and evaluate new technology.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Joslin Diabetes Center
United States
Zip Code
Pavkov, Meda E; Nelson, Robert G; Knowler, William C et al. (2015) Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int 87:812-9
Avadhani, Radhika; Fowler, Kristen; Barbato, Corinne et al. (2015) Glycemia and cognitive function in metabolic syndrome and coronary heart disease. Am J Med 128:46-55
Baskaran, Charumathi; Volkening, Lisa K; Diaz, Monica et al. (2015) A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes 16:263-70
Rasbach, Lisa; Jenkins, Carolyn; Laffel, Lori (2015) An integrative review of self-efficacy measurement instruments in youth with type 1 diabetes. Diabetes Educ 41:43-58
Markowitz, Jessica T; Volkening, Lisa K; Laffel, Lori M B (2014) Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments. J Pediatr 164:1384-9
Castiglioni, Alessandra; Hettmer, Simone; Lynes, Matthew D et al. (2014) Isolation of progenitors that exhibit myogenic/osteogenic bipotency in vitro by fluorescence-activated cell sorting from human fetal muscle. Stem Cell Reports 2:92-106
Isganaitis, Elvira; Woo, Melissa; Ma, Huijuan et al. (2014) Developmental programming by maternal insulin resistance: hyperinsulinemia, glucose intolerance, and dysregulated lipid metabolism in male offspring of insulin-resistant mice. Diabetes 63:688-700
Teo, Adrian Kee Keong; Valdez, Ivan Achel; Dirice, Ercument et al. (2014) Comparable generation of activin-induced definitive endoderm via additive Wnt or BMP signaling in absence of serum. Stem Cell Reports 3:5-14
Lee, Hyung-Yul; Wei, Dan; Loeken, Mary R (2014) Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy. Diabetes Metab Res Rev 30:23-30
Sanders, Kaitlyn; Jung, Jin Hyuk; Loeken, Mary R (2014) Use of a murine embryonic stem cell line that is sensitive to high glucose environment to model neural tube development in diabetic pregnancy. Birth Defects Res A Clin Mol Teratol 100:584-91

Showing the most recent 10 out of 706 publications